FDA Inspection 1106423 — Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
The FDA completed an inspection of Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. on Sep 10, 2019 in Tokushima. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 10, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tokushima (Japan)